Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on X:
“Love ASCO because I can just crash into meetings. Popcorn secured – now waiting for Naveen Pemmaraju to serve up the hematology drama, plot twists, and award-winning stories. Someone cue the theme music!”
Read OncoDaily’s Special Articles about American Society of Clinical Oncology 2025 Annual Meeting:
Highlights from American Society of Clinical Oncology 2025 Annual Meeting: Day 1
Highlights from American Society of Clinical Oncology 2025 Annual Meeting: Day 2
Highlights from American Society of Clinical Oncology 2025 Annual Meeting: Day 3
